Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin
about
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritiThe Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review ArticleResistance to antiplatelet drugs: current status and future researchOrally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluationsEffects of enteric-coated, low-dose aspirin on parameters of platelet functionAspirin resistanceAspirin resistance - does it clinically matter?Aspirin and clopidogrel resistance: consideration and managementThe PFA-100 detects sub-optimal antiplatelet responses in patients on aspirinSuppressive effect of orally administered copper(II)-aspirinate (Cu2(asp)4) complex on the generation of reactive oxygen species in the skin of animals subjected to UVA exposureFrom plant extract to molecular panacea: a commentary on Stone (1763) 'An account of the success of the bark of the willow in the cure of the agues'Improved method of plasma 8-Isoprostane measurement and association analyses with habitual drinking and smoking.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Aspirin for primary prevention of cardiovascular disease in diabetes mellitusAnti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyLow-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative.Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction.Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel.Acetylsalicylic acid supplementation improves protein utilization efficiency while vitamin E supplementation reduces markers of the inflammatory response in weaned pigs challenged with enterotoxigenic E. coli.Antiplatelet medication in cerebrovascular disease: potential sources of controversies and future strategies.The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.Optimizing antiplatelet / antithrombotic therapy.Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha.Fractalkine as an important target of aspirin in the prevention of atherogenesis : Editorial to: "Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice" by H. Liu et al.Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.Safety of continuing aspirin therapy during spinal surgery: A systematic review and meta-analysis.Dietary modulation of oxylipins in cardiovascular disease and aging.Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers.
P2860
Q24235194-4104AEDC-40CF-405A-94CB-E4F0279CDD43Q28075382-88211F05-44EF-4C4B-8D52-B92DF29E5164Q28192298-A7D47514-F371-459E-8BF1-E3FC442C32ADQ28193040-2EA0F346-28E3-4BB8-8826-3C5C50B6E39EQ28193656-E4C6E322-35F4-42F0-9768-14D72A0C813CQ28193808-C82A9D5B-9118-4EAC-B855-424E8D0B640FQ28200100-5064A0D0-8725-4892-9B97-CA06B7657333Q28200610-DD415B39-2567-45F4-933B-B1A7A74CBA78Q28218417-139E77B0-22FB-4348-AE53-FFEEC4BCDD9BQ28219428-1103005E-08A5-4FD6-A2D3-2DA80797ECF5Q28652368-076C823D-9A86-421C-8CC8-61336E9E065DQ33909814-3482F30D-3192-4185-90A9-83D233A8E5D6Q34771381-15E57CA7-D127-4651-90CE-19461374458AQ35132896-3D1E30BF-C4B9-4297-8923-329A8AFE6717Q35373624-7612CDDC-7B46-42D5-9652-12C3463C4577Q36035835-1BE9BEF6-4604-4A43-A3DB-371F85D9A828Q36096803-8831CC58-B847-4AD6-9A35-BE6D209ECA36Q36248969-5649C18A-354F-4687-BE1D-13683F0792C9Q36819758-61A5120F-AE17-49A7-B728-63CC31DC03CCQ36826519-A3A344BE-1108-42F8-84CC-47FC11CC2C6AQ37459006-D651332D-75A1-477C-BA7A-A20487FF7275Q37699576-B196222B-4948-47E5-B63D-6645DEED8B32Q38042445-21275482-0818-4E4F-A953-C865082A9696Q38195191-74298F7A-2197-4BB3-881B-B8DDC713E4F7Q39034536-1E02E8FE-D178-4706-AD64-E71E2C5990D9Q40161287-ECA078CE-F525-4B40-8CC4-40113CF2D6DBQ40509925-70EFB9CB-C16B-446D-99B4-CF75687AA16AQ41046504-749115DC-C013-4C30-9F51-01D937486FEAQ42167751-C9F62DF1-54C5-4947-A322-B491B3853D5FQ42362772-54D91A2C-4908-437F-BC9F-07F9C1EEC6B8Q42604168-F288256E-7B1D-4573-9A62-CEDFA5FBE2DDQ43208567-C4DC54B2-8262-48C0-B261-925B9D1F0AAAQ46790430-68DF7A13-817B-47C8-B021-6BCD4690F190Q47111764-2E6B7801-42F0-4E77-89EB-1D19A80FE810Q48157381-5B4AB716-CF23-441A-A5AB-1121103E5635Q51337243-23AF3E8B-DFB0-473E-AEAB-446E227EFD93
P2860
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@ast
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en-gb
type
label
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@ast
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en-gb
prefLabel
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@ast
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en-gb
P2093
P3181
P1433
P1476
Effects of low-to-high doses o ...... hromboxane A2 and prostacyclin
@en
P2093
P304
P3181
P356
10.1161/01.STR.23.10.1400
P407
P577
1992-10-01T00:00:00Z